Sort
326,823 grants matching “clinical trial”
Data Coordinating Center for Benign Prostate Symptoms
$1,868,158University Of Alabama At Birmingham · U01 · FY2004 · DK
Clinical trials
$1,868,009Robert Freedman · University Of Colorado Denver · U01 · FY2011 · MH
Pharmacogenetics in Rural and Underserved Populations
$1,867,955Kenneth E. Thummel · University Of Washington · U01 · FY2014 · GM
Alphavirus Replicon Vaccines to Encephalitis Viruses
$1,867,474Alphavax Human Vaccines, Inc. · U01 · FY2004 · AI
Mechanisms of GVHD
$1,867,308Joseph H Antin · Dana-Farber Cancer Inst · P01 · FY2011 · CA
Mechanisms of GVHD
$1,867,308Joseph H Antin · Dana-Farber Cancer Inst · P01 · FY2012 · CA
Informed Combination Strategies for Peripheral T-cell Lymphomas
$1,867,112David Marc Weinstock · Dana-Farber Cancer Inst · P01 · FY2019 · CA
Clinical Outcomes in Aicardi Goutières Syndrome
$1,867,066Adeline Lucie Vanderver · Children'S Hosp Of Philadelphia · U01 · FY2019 · NS
Antibody-based Contraceptive MPTs: Preclinical and Clinical Research
$1,867,062Deborah J Anderson · Boston University Medical Campus · P50 · FY2020 · HD
The Health ePeople Resource for Mobilized Research
$1,867,022Jeffrey E Olgin · University Of California, San Francisco · U2C · FY2019 · EB
Prevention of AIDS
$1,866,900Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Conserved Element DNA Vaccine
$1,866,900Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Vaccine and Treatment Evaluation Units
$1,866,737Nadine Georges Rouphael · Emory University · UM1 · FY2021 · AI
Centers for Intervention Development and Applied Research (CIDAR)
$1,866,652William T. Carpenter · University Of Maryland Baltimore · P50 · FY2011 · MH
Characterization of the Osteosarcoma Genome
$1,866,583Paul S. Meltzer · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
NIAID PRECLINICAL DEVELOPMENT SUPPORT: Essential Core Activities
$1,866,402Timothy Fouts · Advanced Bioscience Laboratories, Inc. · N01 · FY2020 · AI
The Health ePeople Resource for Mobilized Research
$1,866,263Jeffrey E Olgin · University Of California, San Francisco · U2C · FY2018 · EB
A Treatment for Patients with Jansens Metaphyseal Chondrodysplasia
$1,866,230Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
Preparing Assisted Living Staff to Care for Persons with Dementia: Palliative Care Education in Assisted Living for Dementia Care Providers
$1,866,197Debra Jean Dobbs · University Of South Florida · RF1 · FY2024 · AG
Predictors of Antidepressant Treatment Response: The Emory CIDAR
$1,866,130Charles B Nemeroff · Emory University · P50 · FY2007 · MH
The Delaware Comprehensive Sickle Cell Research Center
$1,866,125Vicky L Funanage · Nemours Children'S Hospital, Delaware · P20 · FY2018 · GM
THE SCOPE OF THIS TASK ORDER IS (1). PRODUCTION OF A DRUG SUBSTANCE, (2) CONVERSION OF DRUG SUBSTANCE TO DRUG PRODUCT, (3) FILLING DRUG PRODUCT INTO APPLICATORS TO BE USED IN THE CLINICAL TRIALS, AND
$1,866,116Jon White · Midwest Research Institute · N02 · FY2024 · CA
Cornell ME/CFS Collaborative Research Center
$1,866,110Maureen R Hanson · Cornell University · U54 · FY2024 · AI
GHESKIO Clinical Trials Unit
$1,865,917Jean William Pape · Gheskio Center · UM1 · FY2025 · AI
NIAID Preclinical Development Support: Synthesize and Produce HIV-1 Envelope Glycopeptide Immunogen Nanoparticle Vaccine(s)
$1,865,848Thomas Vancott · Advanced Bioscience Laboratories, Inc. · N01 · FY2018 · AI